Effects of janus-kinase inhibitor therapy on lipid parameters in patients with IBD

被引：0
|
作者：
Prabhu, A. [1 ]
Al Dehailan, R. [1 ]
Azzu, H. [1 ]
Sanford, J. [1 ]
Cripps, S. [1 ]
Scaria, L. [1 ]
Walsh, A. [1 ]
机构：
[1] Oxford Univ Hosp NHS Fdn Trust, Translat Gastroenterol Unit, Oxford, England
来源：
JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷
关键词：
RHEUMATOID-ARTHRITIS;
D O I：
10.1093/ecco-jcc/jjae190.1335
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P1161
引用
收藏
页码：i2123 / i2123
页数：1
相关论文
共 50 条
  • [31] ARE THERE ANY ETHNIC DIFFERENCES IN THE RESPONSE TO JANUS KINASE INHIBITOR THERAPY FOR THE TREATMENT OF RHEUMATOID ARTHRITIS?
    Jubber, Ameen
    Hussain, Wajith H. Z.
    Moorthy, Arumugam
    RHEUMATOLOGY, 2022, 61
  • [32] Lung Transplantation under a Janus Kinase Inhibitor in Three Patients with SAVI Syndrome
    Berrada, Kenza Rhzioual
    Belot, Alexandre
    Neven, Benedicte
    Ohlmann, Camille
    Tronc, Francois
    Rice, Gillian
    Thouvenin, Guillaume
    Dubus, Jean-Christophe
    Mazenq, Julie
    Fremond, Marie-Louise
    Stremler, Nathalie
    Soummer-Feuillet, Severine
    Cottin, Vincent
    Reix, Philippe
    JOURNAL OF CLINICAL IMMUNOLOGY, 2023, 43 (08) : 2156 - 2164
  • [33] Aggressive Skin Cancers Occurring in Patients Treated With the Janus Kinase Inhibitor Ruxolitinib
    Blechman, Adam B.
    Cabell, Christine E.
    Weinberger, Christine H.
    Duckworth, Anna
    Leitenberger, Justin J.
    Zwald, Fiona O.
    Russell, Mark A.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2017, 16 (05) : 508 - 511
  • [34] Improvement of cutaneous inflammation and panniculitis in patients with dermatomyositis by the Janus kinase inhibitor baricitinib
    Fischer, Kristina
    Aringer, Martin
    Steininger, Julian
    Heil, Julius
    Beissert, Stefan
    Abraham, Susanne
    Gunther, Claudia
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (03) : 432 - 435
  • [35] Lung Transplantation under a Janus Kinase Inhibitor in Three Patients with SAVI Syndrome
    Kenza Rhzioual Berrada
    Alexandre Belot
    Bénédicte Neven
    Camille Ohlmann
    François Tronc
    Gillian Rice
    Guillaume Thouvenin
    Jean-Christophe Dubus
    Julie Mazenq
    Marie-Louise Frémond
    Nathalie Stremler
    Séverine Soummer-Feuillet
    Vincent Cottin
    Philippe Reix
    Journal of Clinical Immunology, 2023, 43 : 2156 - 2164
  • [36] Effect of tofacitinib, a Janus kinase inhibitor, on haematological parameters during 12 weeks of psoriasis treatment
    Strober, B.
    Buonanno, M.
    Clark, J. D.
    Kawabata, T.
    Tan, H.
    Wolk, R.
    Valdez, H.
    Langley, R. G.
    Harness, J.
    Menter, A.
    Papp, K.
    BRITISH JOURNAL OF DERMATOLOGY, 2013, 169 (05) : 992 - 999
  • [37] Effects of a Janus kinase inhibitor, pyridone 6, on airway responses in a murine model of asthma
    Matsunaga, Yuko
    Inoue, Hiromasa
    Fukuyama, Satoru
    Yoshida, Hideyuki
    Moriwaki, Atsushi
    Matsumoto, Takafumi
    Matsumoto, Koichiro
    Asai, Yukari
    Kubo, Masato
    Yoshimura, Akihiko
    Nakanishi, Yoichi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 404 (01) : 261 - 267
  • [38] The Effects of 5-Aminosalicylic Acid on Janus Kinase Inhibitor Treatment in Ulcerative Colitis
    Dai, Cong
    Huang, Yu-hong
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2025, 40 (03) : 761 - 763
  • [39] Management of vitiligo with topical janus tyrosine kinase inhibitor therapy: An evidence-based review
    Abduelmula, Abrahim
    Mufti, Asfandyar
    Chong, Derrick HY.
    Sood, Siddhartha
    Sachdeva, Muskaan
    Yeung, Jensen
    JAAD INTERNATIONAL, 2022, 9 : 156 - 158
  • [40] Identification and validation of the association of Janus kinase 2 mutations with the response to immune checkpoint inhibitor therapy
    Chen, Peipei
    Long, Junyu
    Zhang, Jiayang
    Xie, Fucun
    Wu, Wei
    Tian, Zhuang
    Zhang, Shuyang
    Yu, Kang
    INFLAMMATION RESEARCH, 2024, 73 (02) : 263 - 276
12345